https://www.selleckchem.com/pr....oducts/pf-07321332.h
A response to Alcici et al., 2019 - thinking about how using conscious sedation for percutaneous mitral commissurotomy may improve outcomes in other areas.Background Endeavor®-zotarolimus-eluting stent (E-ZES) was the first ZES to be developed, and Resolute integrity®-ZES (I-ZES) has been developed more recently. Comparative studies on long-term usage of these two ZESs have been rare. Objectives The aim of this study was to compare the efficacy and safety of E-ZES and I-ZES during a long-term follow-up of patients who underwent perc
Like
Comment
Share
